Sec Form 3 Filing - Exor N.V. @ CLARIVATE PLC - 2024-02-27

FORM 3 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Exor N.V. 2. Issuer Name and Ticker or Trading Symbol CLARIVATE PLC [ CLVT] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director X __ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) GUSTAV MAHLERPLEIN 25A 3. Date of Earliest Transaction (MM/DD/YY) 02/27/2024 (Street) AMSTERDAM, P71082 MS 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) _____ Form filed by One Reporting Person __ X __ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Ordinary shares, no par value 67,294,884 ( 1 ) I See Footnote.

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Exor N.V. GUSTAV MAHLERPLEIN 25A AMSTERDAM, P71082 MS X Giovanni Agnelli B.V. GUSTAV MAHLERPLEIN 25A AMSTERDAM, P71082 MS X Exor Nederland N.V. GUSTAV MAHLERPLEIN 25A AMSTERDAM, P71082 MS X Signatures Exor N.V., by: /s/ Guido de Boer, Name: Guido de Boer, Title: Authorized Signatory 03/08/2024 Signature of Reporting Person Date Giovanni Agnelli B.V., by: /s/ Guido de Boer, Name: Guido de Boer, Title: Authorized Signatory 03/08/2024 Signature of Reporting Person Date Exor Nederland N.V., by: /s/ Guido de Boer, Name: Guido de Boer, Title: Authorized Signatory 03/08/2024 Signature of Reporting Person Date

Explanation of Responses:

( 1 )The reported ordinary shares are held directly by Exor Nederland N.V., which is a wholly-owned subsidiary of Exor N.V., which in turn is controlled by Giovanni Agnelli B.V. Exor N.V. and Giovanni Agnelli B.V. are indirect beneficial owners of the reported ordinary shares.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.